17.96 (-%)
As of Nov 20, 2024
Source:
HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases.
| Country | Canada |
| Headquarters | hong kong |
| Phone Number | 852-2121-3888 |
| Industry | manufacturing |
| CEO | Weiguo Su |
| Website | www.hutch-med.com/shareholder-information. |